Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.099 USD | +0.51% | +1.43% | -42.74% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sean Carrick
CEO | Chief Executive Officer | 56 | 15/14/15 |
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15/14/15 |
Douglas Karas
BRD | Director/Board Member | 59 | 04/16/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lowell Holden
DFI | Director of Finance/CFO | 82 | 15/14/15 |
Sean Carrick
CEO | Chief Executive Officer | 56 | 15/14/15 |
Douglas Karas
BRD | Director/Board Member | 59 | 04/16/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 169,729,565 | 101,841,640 ( 60.00 %) | 0 | 60.00 % |
Company contact information
Nascent Biotech, Inc.
623 US Highway 1 Suite 407
33408, North Palm Beach
+
http://www.nascentbiotech.comSector
1st Jan change | Capi. | |
---|---|---|
-42.74% | 1.69Cr | |
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |
- Stock Market
- Equities
- NBIO Stock
- Company Nascent Biotech, Inc.